StockWatch
·

Stallion India Fluorochemicals Ltd

BSE: 544342

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
139.37
+11.8%+31.8%
Expenditure
133.63
+33.8%+47.6%
Net Profit
2.45
-86.8%-78.5%
OPM %
2.19%
-15.96pp-12.56pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0042.8985.77128.66171.54Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Stallion India Q2 PAT sinks 79% YoY to ₹2.45 Cr as input costs, ESOP charge crush margins

fluorochemicals · margin compression · input cost inflation

ResultsQ2 FY2713 Nov 20263 minMetals & Mining

Can Stallion sustain Q1's margin burst as helium facility ramps?

fluorochemicals · semiconductor gas · margin expansion

Result previewQ2 FY2713 Nov 20263 minMetals & Mining

Strong earnings, deflated by guidance cuts and margin quality

R32 manufacturing · backward integration · execution delay

Result verdictFollow-upQ1 FY2720 Aug 20266 minMetals & Mining
Latest
Quarterly Result13 Nov, 1:36 pm

Stallion India Q2 PAT sinks 79% YoY to ₹2.45 Cr as input costs, ESOP charge crush margins

Stallion India Fluorochemicals' standalone Q2 FY27 print is a clear miss on profitability even as revenue held up: revenue from operations grew 28.9% YoY (and 12.0% QoQ) to ₹136.03 Cr, ahead of our pre-result on-plan range of ₹120-128 Cr, but PAT collapsed 78.5% YoY and 86.8% QoQ to just ₹2.45 Cr, with EPS falling to ₹0.21 from ₹1.60 in Q1 FY27 and ₹1.42 a year ago. There is no formal sell-side coverage on this stock (0 analysts per public trackers), so the only external yardstick is our own preview, which had flagged ~14-15% PAT margin and ~₹20-23 Cr EBITDA as the on-plan bar; actual PAT margin came in at 1.8% and reported EBITDA (PBT less other income, plus finance costs and depreciation) at just ₹2.98 Cr — a clear miss on profitability despite the revenue beat. Two factors drove the collapse. First, a one-off: the company booked a ₹9.51 Cr non-cash ESOP expense (15,86,505 options granted at a Black-Scholes fair value of ₹128.69/option) entirely within Q2, per Note 5 of the filing — this alone explains most of the ~5x jump in employee costs. Adjusting for it, PAT would have been roughly ₹11.96 Cr, a YoY growth of just +4.8% (essentially flat) rather than the reported -78.5%. Second, and more concerning, raw material costs consumed 88.2% of revenue this quarter versus 62.5% in Q1 FY27 and 75.1% in the year-ago quarter — even stripping out the ESOP charge, OPM works out to roughly 9.2%, still down sharply from 18.15% in Q1 FY27 and 14.75% a year ago. Management's prior guidance (Q1 FY27 concall) had called for EBITDA margins to improve 3-4 percentage points over the medium term; this quarter moved in the opposite direction by several hundred basis points even on an adjusted basis, a direct miss against that outlook. Revenue growth of 28.9% YoY is roughly tracking, if a touch below, the guided 30-35% three-year revenue CAGR. No management press release or concall commentary for this specific quarter is available in our records, so there is no company framing to cross-check against the numbers beyond the filing itself. The quarter's other disclosed developments — commercial start-up of the Semiconductor Gas facility at Khalapur (Sept 21, 2026) and conclusion of a GST inspection with tax paid (Oct 15, 2026, quantum not separately disclosed in this filing) — sit alongside the print but aren't yet visible as margin drivers; the semiconductor ramp is still early. Half-year PAT (₹21.02 Cr) is down 3.5% YoY despite 19.2% YoY revenue growth to ₹257.48 Cr, showing the margin pressure is not confined to a single quarter's optics.

13 Nov 2026, 01:36 pm

Corporate Events

Board MeetingSTALLION
2026
13Nov

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingSTALLION
2026
21Sep

Board Meeting

The 24th Annual General Meeting of the Company will be held …

BSE Filing ↗
Board MeetingSTALLION
2026
12Aug

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingSTALLION
2026
5Feb

Board Meeting

Approval of Rights Issue, Equity shares to be offered throug…

BSE Filing ↗
Board MeetingSTALLION
2026
23Jan

Board Meeting

Consider and approve

BSE Filing ↗
Board MeetingSTALLION
2026
21Jan

Board Meeting

Consider, .... Pursuant to Regulation 29 of the Securities a…

BSE Filing ↗